Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series

Harindra Rajasekeran; S Joseph Kim; Carl J Cardella; Jeffrey Schiff; Mark Cattral; David Z I Cherney; Sunita K S Singh

doi:10.2337/dc17-0237

Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series

Diabetes Care. 2017 Jul;40(7):e75-e76. doi: 10.2337/dc17-0237. Epub 2017 Apr 17.

Authors

Harindra Rajasekeran^{1

2}, S Joseph Kim^{1

3

4}, Carl J Cardella^{1

3}, Jeffrey Schiff^{1

3

5}, Mark Cattral^{5

6}, David Z I Cherney^{1

2}, Sunita K S Singh^{7

3

5}

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada.
² Department of Physiology, University of Toronto, Toronto, Canada.
³ Kidney Transplant Program, Toronto General Hospital, University Health Network, Toronto, Canada.
⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
⁵ Pancreas Transplant Program, Toronto General Hospital, University Health Network, Toronto, Canada.
⁶ Division of General Surgery, Department of Surgery, University of Toronto, Toronto, Canada.
⁷ Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada [email protected].

PMID: 28416475
DOI: 10.2337/dc17-0237

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't